|
|
|
|
|
|
|
|
Conclusion: "Despite a favorable impact of carboplatin and PLD on progression-free survival in this trial, the effect on overall survival is not statistically significant. For currently unknown reasons, administering PLD with carboplatin appears to substantially reduce the incidence of platinum-associated hypersensitivity reactions."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.